We are live on
!
Find out more
PCM
Polaris Capital Management Portfolio holdings
AUM
$1.06B
1-Year Est. Return
40.82%
This Fund
S&P 500
This Quarter
Est. Return
+13.5%
1 Year Est. Return
+40.82%
3 Year Est. Return
+94.3%
5 Year Est. Return
+113.49%
10 Year Est. Return
+358.47%
AUM
$3.05B
AUM Growth
+$387M
(+15%)
Cap. Flow
-$147M
Cap. Flow
% of AUM
-4.82%
Top 10 Holdings %
Top 10 Hldgs %
45.34%
Holding
111
New
11
Increased
15
Reduced
53
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Therapeutics
UTHR
|
+$63.4M |
| 2 |
Marathon Petroleum
MPC
|
+$7.81M |
| 3 |
BERY
Berry Global Group, Inc.
BERY
|
+$7.63M |
| 4 |
CVS Health
CVS
|
+$6.15M |
| 5 |
FNHC
FedNat Holding Company Common Stock
FNHC
|
+$2.36M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tapestry
TPR
|
+$51M |
| 2 |
Franklin Resources
BEN
|
+$37.3M |
| 3 |
Popular Inc
BPOP
|
+$23.5M |
| 4 |
Dime Commercial Bancshares
DCOM
|
+$10.7M |
| 5 |
Webster Financial
WBS
|
+$9.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 29.78% |
| 2 | Healthcare | 14.72% |
| 3 | Technology | 13.45% |
| 4 | Consumer Discretionary | 10.35% |
| 5 | Consumer Staples | 10.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Popular Inc
BPOP
$11B
| $281M | 9.21% |
3,612,878
-362,282
| -9% | -$23.5M |
|
2
Coca-Cola Europacific Partners
CCEP
$49.1B
| $201M | 6.58% |
3,553,183
+6,117
| +0.2% | +$311K |
|
3
Linde
LIN
$236B
| $187M | 6.12% |
620,003
+2,973
| +0.5% | +$771K |
|
4
Amcor
AMCR
$21.2B
| $166M | 5.46% |
2,672,554
-9,235
| -0.3% | -$526K |
|
5
Infosys
INFY
$51B
| $159M | 5.21% |
8,651,704
-79,432
| -0.9% | -$1.44M |
|
6
Crocs
CROX
$6.63B
| $87.5M | 2.87% |
839,455
-56,000
| -6% | -$4.27M |
|
7
Capital One
COF
$128B
| $79.7M | 2.62% |
506,508
-37,000
| -7% | -$4.36M |
|
|
8
Webster Financial
WBS
$12.3B
| $75.5M | 2.48% |
1,364,961
-173,100
| -11% | -$9.22M |
|
9
JPMorgan Chase
JPM
$916B
| $74.1M | 2.43% |
459,351
-19,400
| -4% | -$2.79M |
|
|
10
United Therapeutics
UTHR
$26.1B
| $72.2M | 2.37% |
+380,500
| New | +$63.4M |
|
|
11
Marathon Petroleum
MPC
$90.1B
| $71.9M | 2.36% |
1,202,694
+154,700
| +15% | +$7.81M |
|
12
Grupo Cibest SA
CIB
$21.2B
| $67.4M | 2.21% |
2,111,090
-108,400
| -5% | -$3.85M |
|
13
Cinemark Holdings
CNK
$4.07B
| $65.9M | 2.16% |
3,065,158
-246,500
| -7% | -$5.2M |
|
|
BERY
14
DELISTED
Berry Global Group, Inc.
BERY
| $65.6M | 2.15% |
1,050,558
+147,015
| +16% | +$7.63M |
|
15
Arrow Electronics
ARW
$10.5B
| $64.9M | 2.13% |
553,003
-50,300
| -8% | -$5.23M |
|
|
16
CVS Health
CVS
$135B
| $64.1M | 2.1% |
747,000
+84,400
| +13% | +$6.15M |
|
17
Ameris Bancorp
ABCB
$5.89B
| $63.7M | 2.09% |
1,141,665
-106,000
| -8% | -$5.04M |
|
18
International Bancshares
IBOC
$4.77B
| $62.1M | 2.04% |
1,265,306
-144,500
| -10% | -$6.35M |
|
19
Tyson Foods
TSN
$21.5B
| $58.2M | 1.91% |
738,263
-14,900
| -2% | -$1.03M |
|
20
Elevance Health
ELV
$81.5B
| $56.3M | 1.85% |
140,151
-10,900
| -7% | -$3.51M |
|
21
Labcorp
LH
$25.2B
| $53.8M | 1.76% |
225,895
-36,783
| -14% | -$7.38M |
|
22
Chubb
CB
$140B
| $53.1M | 1.74% |
305,749
-25,000
| -8% | -$4.03M |
|
|
ALXN
23
DELISTED
Alexion Pharmaceuticals
ALXN
| $52.7M | 1.73% |
306,900
-36,000
| -10% | -$5.57M |
|
24
Microsoft
MSFT
$2.9T
| $52.6M | 1.73% |
212,926
-13,200
| -6% | -$3.06M |
|
|
ALE
25
DELISTED
Allete
ALE
| $51.1M | 1.68% |
717,758
-66,800
| -9% | -$4.38M |
|
Similar funds
HMH
BGIM
EC
MFS
ZIG
MWA
DCP
SFP
Polaris Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Polaris Capital Management held 111 positions worth $3.05B, up 15% from $2.66B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Polaris Capital Management withdrew a net $147M in Q1 2021, closing 9 positions and reducing 53 holdings. Its most notable exit was Tapestry, an estimated $51M position sold in full.
By sector, the portfolio is most concentrated in Financials at 30% of assets, down from 30% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Polaris Capital Management opened a new position in United Therapeutics worth $72.2M.
- Polaris Capital Management's largest Q1 2021 buy was United Therapeutics: 380,500 shares worth $72.2M.
- Polaris Capital Management added most to Marathon Petroleum in Q1 2021, an estimated $7.81M increase.
- Polaris Capital Management's biggest Q1 2021 reduction was Popular Inc, cutting an estimated $23.5M.
- Polaris Capital Management fully exited Tapestry in Q1 2021, selling an estimated $51M.
- Polaris Capital Management's ten largest holdings make up 45% of its $3.05B portfolio in Q1 2021.
- Polaris Capital Management opened 11 new positions and closed 9 in Q1 2021.
- Polaris Capital Management's portfolio value rose 15% quarter-over-quarter to $3.05B.
Based on Polaris Capital Management's 13F filing for Q1 2021, filed 11 May 2021.